FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

703640000: Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3677881012 Crizotinib 250 mg oral capsule en Synonym Active Entire term case insensitive SNOMED CT core module
3677882017 Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
87558101000001116 Crizotinib 250mg capsules en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Is a Product containing crizotinib false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has manufactured dose form Conventional release oral capsule false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has active ingredient Crizotinib false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has active ingredient Crizotinib false Inferred relationship Existential restriction modifier 1
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has basis of strength substance Crizotinib true Inferred relationship Existential restriction modifier 1
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has presentation strength numerator value 250 false Inferred relationship Existential restriction modifier 1
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has presentation strength denominator unit Capsule true Inferred relationship Existential restriction modifier 1
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has precise active ingredient Crizotinib true Inferred relationship Existential restriction modifier 1
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has unit of presentation Capsule false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Is a Product containing crizotinib in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Is a Product containing only crizotinib in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has active ingredient Crizotinib false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has manufactured dose form Conventional release oral capsule false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has unit of presentation Capsule false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route capsule.oral ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has manufactured dose form Conventional release oral capsule false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has unit of presentation Capsule false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has unit of presentation Capsule false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has manufactured dose form Conventional release oral capsule false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Is a Crizotinib true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has specific active ingredient Crizotinib true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xalkori 250mg capsules (Originalis B.V.) Is a True Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Inferred relationship Existential restriction modifier
Xalkori 250mg capsules (Pfizer Ltd) Is a True Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Inferred relationship Existential restriction modifier
Xalkori 250mg capsules (Imported (United States)) Is a True Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Inferred relationship Existential restriction modifier
Crizotinib 250mg capsules 60 capsule Has VMP True Product containing precisely crizotinib 250 milligram/1 each conventional release oral capsule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start